Aviva’s Carlisle Companies CSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Sell
34,273
-3,837
-10% -$1.34M 0.02% 517
2026
Q1
$12.7M Buy
38,110
+1,284
+3% +$467K 0.02% 488
2025
Q4
$11.8M Buy
36,826
+2,717
+8% +$881K 0.02% 520
2025
Q3
$11.2M Sell
34,109
-37,104
-52% -$14.1M 0.02% 516
2025
Q2
$26.6M Sell
71,213
-64,297
-47% -$23.9M 0.05% 305
2025
Q1
$46.1M Sell
135,510
-17,969
-12% -$6.44M 0.11% 205
2024
Q4
$56.6M Buy
153,479
+20,520
+15% +$8.95M 0.15% 146
2024
Q3
$59.8M Buy
132,959
+24,948
+23% +$10.3M 0.15% 151
2024
Q2
$43.8M Buy
+108,011
New +$43.5M 0.12% 195
2023
Q3
Sell
-5,649
Closed -$1.45M 979
2023
Q2
$1.45M Sell
5,649
-32,682
-85% -$7.24M 0.01% 730
2023
Q1
$8.67M Buy
38,331
+1,538
+4% +$374K 0.04% 481
2022
Q4
$8.67M Buy
36,793
+4,727
+15% +$1.22M 0.04% 483
2022
Q3
$8.99M Buy
+32,066
New +$9.19M 0.05% 457
2020
Q2
Sell
-29,581
Closed -$3.71M 948
2020
Q1
$3.71M Buy
29,581
+17,715
+149% +$2.63M 0.03% 534
2019
Q4
$1.92M Buy
+11,866
New +$1.83M 0.01% 760

Other funds holding CSL

Aviva's CSL Position: Q2 2026 in Review

Aviva reduced its Carlisle Companies (CSL) stake by 10% in Q2 2026, selling an estimated $1.34M and leaving 34,273 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #517.

Aviva first reported a position in CSL in Q4 2019 and has held it in 15 quarters since. The position peaked at $59.8M in Q3 2024. 792 funds tracked by Wall St. Rank hold CSL as of Q2 2026.

  • Aviva held 34,273 shares of Carlisle Companies worth $12.4M as of Q2 2026.
  • Aviva sold 3,837 Carlisle Companies shares in Q2 2026, an estimated $1.34M.
  • Carlisle Companies made up 0.02% of Aviva's portfolio in Q2 2026, its #517 holding.
  • Aviva first reported a position in Carlisle Companies in Q4 2019 and has held it in 15 quarters since.
  • Aviva's Carlisle Companies position peaked at $59.8M in Q3 2024.
  • 792 funds tracked by Wall St. Rank held Carlisle Companies as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.